Tech Company Financing Transactions

Sequenta Funding Round

On 12/8/2010, Sequenta landed $13 million in Series B funding from Index Ventures, Mohr Davidow Ventures and private investors.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

400 East Jamie Court 301
South San Francisco, CA 94080
USA

Phone

888-552-8988

Website

www.sequentainc.com

Email Address

Not Recorded

Overview

Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Tom Willis

        

Chief Scientific Officer

Malek Faham

        

Browse more venture capital transactions:

Prev: 12/8/2010: Kicktag venture capital transaction
Next: 12/8/2010: Ortho Kinematics venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary